COMPARISON OF BUSULFAN/CYCLOPHOSPHAMIDE ALONE AND IN COMBINATION WITH THIOTEPA OR ANTI-THYMOCYTE GLOBULIN ON HEMATOPOIETIC STEM CELL TRANSPLANTATION OUTCOME AMONG BETA-THALASSEMIA PATIENTS
EHA Learning Center, Saqib Ansari, 215776
SECOND TRANSPLANT FOR PRIMARY GRAFT FAILURE , FOLLOWING HAPLOIDENTICAL GRAFTS WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE
EHA Learning Center, SABRINA GIAMMARCO, 215777
SUBPOPULATIONS OF MONOCYTES AND B REGULATORY CELLS IN PATIENTS WITH CHRONIC GRAFT-VERSUS-HOST DISEASE
EHA Learning Center, Drazen Pulanic, 215778
LIFESTYLE BEHAVIOR AMONG LYMPHOMA SURVIVORS AFTER HIGH DOSE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Learning Center, Hanne Bersvendsen, 215779
CTLA-4 GENE POLIMORPHISM INFLUENCE THE OUTCOME OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Learning Center, Petra Kovy, 215780
ELDERLY PATIENTS WITH MULTIPLE MYELOMA: LONG-TERM OUTCOME FOLLOWING INDUCTION WITH NOVEL DRUGS AND AUTOLOGOUS STEM CELL TRANSPLANT
EHA Learning Center, Swabirah Rassool, 215781
SEVERE PRE-ALLO-HSCT IRON OVERLOAD (IO), MEASURED BY LIVER MRI, SIGNIFICANTLY IMPAIRED THE PROCEDURE LONG-TERM OUTCOME
EHA Learning Center, VALLEJO LLAMAS JUAN CARLOS, 215782
INCIDENCE AND RISK FACTORS FOR THE DEVELOPMENT OF HEMORRHAGIC CYSTITIS ON HAPLOIDENTICAL TRANSPLANTATION
EHA Learning Center, Cynthia ACOSTA FLEITAS, 215783
THREE MONTH FULL WHOLE BLOOD AND MIXED T CELL CHIMERISM IS ASSOCIATED WITH SUPERIOR OUTCOMES IN REDUCED-INTENSITY ALEMTUZUMAB-BASED ALLOGENEIC STEM CELL TRANSPLANTS FOR HAEMATOLOGICAL MALIGNANCIES
EHA Learning Center, Alexandros Kanellopoulos, 215784
OUTCOMES OF SECOND ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSE OF HEMATOLOGICAL DISEASES OR GRAFT FAILURE: A SINGLE-CENTRE EXPERIENCE
EHA Learning Center, Monica Poiani, 215785
CLOFARABINE- BASED CYTOREDUCTIVE TREATMENT FOLLOWED BY MYELOABLATIVE CONDITIONING AND ALLOGENEIC STEM CELL TRANSPLANTATION IN CHILDREN WITH HIGH-RISK, RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES.
EHA Learning Center, DIEGO MEDINA VALENCIA, 215786
SELECTIVE INHIBITION OF OXIDATIVE PHOSPHORYLATION PREVENTS LETHAL GRAFT-VERSUS-HOST DISEASE WHILE MAINTAINING ANTITUMOR IMMUNITY
EHA Learning Center, Zachariah McIver, 215787
AN UNBALANCED MONOCYTE MACROPHAGE POLARIZATION IN THE BONE MARROW MICROENVIRONMENT MAY CAUSE THE OCCURRENCE OF POOR GRAFT FUNCTION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Learning Center, Hong-Yan Zhao, 215788
COMPLEMENT-RELATED GENETIC VARIANTS IN ADULT ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS WITH TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY
EHA Learning Center, Eleni Gavriilaki, 215789
MURINE MODELS FOR ESTABLISHING STEROID REFRACTORY GVHD
EHA Learning Center, Tomomi Toubai, 215790
LOW-DOSE INTERLEUKIN-2 RESTORING HUMAN REGULATORY T CELL FUNCTION IN VITRO AS A POTENTIAL APPLICATION FOR GVHD THERAPY AFTER TRANSPLANTATION
EHA Learning Center, Tzeon-Jye Chiou, 215791
HYPOFRACTIONATED TOTAL LYMPHOID IRRADIATION BY HELICAL TOMOTHERAPY AND HIGH DOSE CHEMOTHERAPY AS CONDITIONING FOR AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH RELAPSED/REFRACTORY LYMPHOMA
EHA Learning Center, Fabio Guolo, 215792
THE RELATIONSHIP BETWEEN SELECTIVE PRE-TRANSPLANTATION IMMUNE PARAMETERS AND EARLY INFECTIONS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES UNDERGOING ASCT – PRELIMINARY REPORT
EHA Learning Center, Agnieszka Szymczyk, 215793
SELECTIVE HSC-ABLATION USING ANTI-CD117 ANTIBODY DRUG CONJUGATE ENABLES SAFE AND EFFECTIVE AUTOLOGOUS AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Learning Center, Agnieszka Czechowicz, 215794
SERUM YKL-40 LEVELS IN PATIENTS WITH B-THALASSEMIA: RELATION TO VIRAL HEPATITIS, LIVER STIFFNESS AND HEPATIC IRON CONCENTRATION.
EHA Learning Center, Samah Mostafa, 215795
THE STRONG LINK BETWEEN PANCREAS AND HEART IN THALASSEMIA MAJOR.
EHA Learning Center, Alessia Pepe, 215796
A SIMPLE NGS METHOD FOR DETECTION OF MUTATIONS CAUSING ALPHA AND BETA THALASSEMIA
EHA Learning Center, Mehmet Uzunel, 215797
PRE- AND POST-TRANSFUSION COMPLEMENT ACTIVATION IN TRANSFUSION-DEPENDENT Β-THALASSAEMIA
EHA Learning Center, Eleni Gavriilaki, 215798
ASSOCIATION OF CLINICAL PHENOTYPE OF THALASSEMIA WITH COMMON FETAL HEMOGLOBIN VARIANTS IN LEBANESE PATIENTS BEARING THE CODON 29 ΒETA GENE MUTATION
EHA Learning Center, Ali Taher, 215799
THALASSEMIA PREVENTION PROGRAM IN DEVELOPING WORLD SCENARIO: 13 YEARS EXPERIENCE
EHA Learning Center, Kousar Perveen, 215800
ASSOCIATION OF VITAMIN D AND RETINOID X RECEPTORS EXPRESSION AND VITAMIN D BINDING PROTEIN VARIANTS WITH BONE DENSITY IN THALASSEMIA CHILDREN
EHA Learning Center, shaimaa sahmoud, 215801
NEW OCCURRENCES OF MACROSCOPIC MYOCARDIAL FIBROSIS IN THALASSEMIA AT LONG TERM BY MULTIPLE FOLLOW-UP
EHA Learning Center, Alessia Pepe, 215802
COMMON LINK BETWEEN BONE AND HEART HEALTH IN THALASSEMIA MAJOR.
EHA Learning Center, Alessia Pepe, 215803
CEREBRAL IRON OVERLOAD IN BETA THALASSEMIA: DOES IT REALLY MATTER?
EHA Learning Center, Immacolata Tartaglione, 215805
LEPTIN IS ASSOCIATED WITH THE DEGREE OF ANEMIA AND THE ERYTHROPOIETIN LEVELS IN Β THALASSEMIA PATIENTS
EHA Learning Center, Carina Levin, 215806
MUTATION SPECTRUM IN HBB, HBA1 AND HBA2 GENES IN PATIENTS FROM EUROPEAN PART OF RUSSIA
EHA Learning Center, Svetlana Mann, 215807
COMPREHENSIVE SCREENING FOR COEXISTING HETEROZYGOUS Α0-THALASSEMIA IN HEMOGLOBIN E TRAIT
EHA Learning Center, Piroonrut Wongprachar, 215808
ARE ALL DIRECT ORAL ANTICOAGULANTS EQUAL TO SAFETY AND EFFICACY?
EHA Learning Center, Begoña Navarro Almenzar, 215809
ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA AND ACUTE PANCREATITIS: VARIABLE AND RECIPROCAL PATHOPHYSIOLOGIC RELATIONSHIPS
EHA Learning Center, Qian (Janie) Qin, 215810
EVALUATION OF LUPUS ANTICOAGULANT TESTING: A THREE YEAR EXPERIENCE
EHA Learning Center, Isabel Izquierdo García, 215811
THE INFLUENCE OF PGP AND PGR PEPTIDES ON ANTICOAGULANT CAPACITY AND ANTITHROMBOTIC POTENTIAL OF BLOOD IN HEMOSTATIC DYSFUNCTION OF AGING RATS
EHA Learning Center, Tamara Obergan, 215812
APTT-BASED CLOT WAVEFORM ANALYSIS IN VARIOUS INFECTIONS
EHA Learning Center, Cheng Kiat Lawrence Ng, 215813
ANTITHROMBOTIC EFFECTS OF COMPLEX PREPARATIONS OF VEGETABLE HEPARINOID WITH LEUCINE
EHA Learning Center, Margarita Lyapina, 215814
C-TERMINAL FRAGMENTS OF NEUROPEPTIDES CHANGE INTERACTION OF BLOOD CELLS IN THROMBOGENESIS
EHA Learning Center, Maria Golubeva, 215815
COMPARATIVE STUDY OF DALTEPARIN SODIUM AND ACETYLSALICYLIC ACID IN PREVENTION OF ANTIPHOSPHOLID SYNDROM ASSOTIATED WITH RECURRENT PREGNANCY MISCARRIAGE.
EHA Learning Center, Dimitry Marinitch, 215816
LABORATORY CRITERIA FOR THE DIAGNOSTIC RELIABILITY OF TESTS FOR DETECTION OF LUPUS ANTICOAGULANT IN PATIENTS WITH SUSPECTED ANTIPHOSPHOLIPID SYNDROME
EHA Learning Center, Valeriia Krasivska, 215817
THE COAGULATION SYSTEM FUNCTIONING IN PATIENTS WITH MYELOFIBROSIS
EHA Learning Center, Elizaveta Efremova, 215818
PLATELET MAPPING BY THROMBOELASTOGRAPHY- ASSESSMENT OF PLATELET INHIBITION SECONDARY TO ANTIPLATELET THERAPY AFTER PCI
EHA Learning Center, DIBYENDU DE, 215819
IMMATURE PLATELET FRACTION: A USEFUL MARKER FOR IDENTIFYING THE CAUSE OF THROMBOCYTOPENIA AND PREDICTING PLATELET RECOVERY
EHA Learning Center, Eunyup Lee, 215820
PLATELETPHERESIS-ASSOCIATED LYMPHOPENIA IN FREQUENT PLATELET DONORS
EHA Learning Center, John Gansner, 215821
INTRACRANIAL HEMORRHAGE IN LEUKEMIA PATIENTS: PRELIMINARY RESULTS OF AN ONGOING NESTED CASE CONTROL STUDY
EHA Learning Center, Loes Cornelissen, 215822
QUALITY CONTROL IN CRYOPRESERVED POOLED PLATELETS: 9-YEAR EXPERIENCE IN A TRANSFUSION CENTRE.
EHA Learning Center, Pablo Romero Garcia, 215823
BACTERIAL CONTAMINANTS AND BIOFILMS EFFECT PLATELET ACTIVATION AND FUNCTION: IMPLICATIONS IN PLATELET TRANSFUSIONS
EHA Learning Center, Joels Wilson-Nieuwenhuis, 215824
ALLOIMMUNIZATION TO D AND NON-D RHESUS ANTIGENS INDUCED BY PLATELET TRANSFUSIONS
EHA Learning Center, Michael Daskalakis, 215825
MASSIVE TRANSFUSION PROTOCOLS - FRIEND OR FOE ?
EHA Learning Center, Moon Ley Tung, 215826
PLATELET-DERIVED MICROPARTICLES; THE EXPRESSION PROPERTIES AND POTENSIAL AS A SUBSTITUTE FOR PLATELETS
EHA Learning Center, Shima Azadpour, 215827
MIR-497~195 CLUSTER IS ASSOCIATED WITH FAVORABLE OUTCOME AND HAS A TUMOR SUPPRESSIVE FUNCTION IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Learning Center, Elena Boldrin, 215890
MICRORNA-142 IS AN ESSENTIAL REGULATOR OF B CELL DEVELOPMENT AND MALIGNANT TRANSFORMATION
EHA Learning Center, Wei-Le Wang, 215891
AN ESSENTIAL ROLE OF LCK IN T-ALL CELL PROLIFERATION AND SURVIVAL
EHA Learning Center, Yuzhe Shi, 215892
METABOLOMIC ANALYSIS REVEALS CEREBROSPINAL FLUID CREATINE AND XANTHINE CONCENTRATIONS AS POTENTIAL BIOMARKERS FOR CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ACUTE LYMPHOBLASTIC LEUKAEMIA
EHA Learning Center, Antony Cousins, 215893
PROGNOSTIC VALUE OF IKZF1 DELETIONS ON THE UKALL14 TRIAL; SIGNIFICANT ROLE OF BCR-ABL1 STATUS
EHA Learning Center, Rachel Mitchell, 215894
EVALUATION OF CORRELATION BETWEEN EARLY IMMATURE T-ALL IMMUNOPHENOTYPE, ABSENCE OF BIALLELIC DELETION OF TCR-Γ AND MEF2C EXPRESSION
EHA Learning Center, Jay SINGH, 215895
NATIONAL EARLY WARNING SCORE (NEWS), QUICK SEQUENTIAL (SEPSIS-RELATED) ORGAN FAILURE ASSESSMENT (QSOFA) AND MICROBIOLOGICAL EVALUATION IN FEBRILE NEUTROPENIA OF ACUTE MYELOID LEUKEMIA
EHA Learning Center, Barbara Nicolino, 215896
LENALIDOMIDE PLUS BENDAMUSTINE-RITUXIMAB DOES NOT OVERCOME THE ADVERSE IMPACT OF TP53 MUTATIONS IN MANTLE CELL LYMPHOMA
EHA Learning Center, Christian Winther Eskelund, 215897
HIGH RISK AGGRESSIVE B-CELL LYMPHOMAS IDENTIFIED BY FISH: A MULTICENTRIC RETROSPECTIVE STUDY FROM CENTERS OF THE FONDAZIONE ITALIANA LINFOMI
EHA Learning Center, Maria Chiara Tisi, 215898
GAU-PED STUDY: UPDATE ON RESULTS AND LONG-TERM OUTCOME OF PATIENTS WITH GAUCHER DISEASE DIAGNOSED THROUGH A PAEDIATRIC ALGORITHM
EHA Learning Center, William Morello, 215899
ENHANCED BONE MARROW HOMING OF NATURAL KILLER CELLS FOLLOWING MRNA TRANSFECTION WITH GAIN-OF-FUNCTION CXCR4
EHA Learning Center, Emily Levy, 215900
INTERLEUKIN-15-CULTURED DENDRITIC CELLS ENHANCE ANTI-TUMOR GAMMA DELTA T CELL FUNCTIONS THROUGH IL-15 SECRETION
EHA Learning Center, Heleen Van Acker, 215901
PI3P MODULATES MEGAKARYOCYTE MATURATION AND PROPLATELET PRODUCTION IN VITRO
EHA Learning Center, Ivana Bertović, 215902
NIVOLUMAB TREATMENT DISCONTINUATION IN RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY EXPERIENCE
EHA Learning Center, Liudmila Fedorova, 215903
RELEVANCE OF PRE AND POST TRANSPLANT PET AND HASENCLEVER INDEX IN PATIENTS UNDERGOING AUTOLOGOUS TRANSPLANT FOR HODGKIN LYMPHOMA
EHA Learning Center, Siddharth Turkar, 215904
A REAL WORLD STUDY OF CLINICAL CHARACTERISTICS AND TREATMENT OUTCOME OF HODGKIN LYMPHOMA IN MALAYSIA: A SINGLE CENTER EXPERIENCE IN A RESOURCE LIMITED SETTING
EHA Learning Center, Tze Shin Leong, 215905
INTESTINAL COLONIZATION BY MULTIDRUG-RESISTANT GRAM-NEGATIVE PATHOGENS IN HEMATOLOGICAL PATIENTS: REAPPRAISAL OF SELECTIVE ORAL DECONTAMINATION
EHA Learning Center, Igor Stoma, 215906
EMERGING MICROBIAL RESISTANCE IN FEBRILE NEUTROPENIA- IS IT HIGH TIME TO EVALUATE QUALITY CONTROL MEASURES?
EHA Learning Center, Nida Anwar, 215907
BONE MARROW FAILURE AND PREDISPOSITION TO LEUKEMIA IN GATA2 HAPLOINSUFFICIENT MICE
EHA Learning Center, Julia Weiss, 215908
WHOLE EXOME SEQUENCING OF SYSTEMIC LIGHT CHAIN (AL) AMYLOIDOSIS
EHA Learning Center, Isabel Cuenca Navarro, 215909
A HIGH LEVEL OF GENOMIC COMPLEXITY CORRELATES WITH ADVANCED PLASMA CELL DIFFERENTIATION STAGES IN NEWLY DIAGNOSED MM PATIENTS
EHA Learning Center, Marina Martello, 215910
DETECTION OF MYD88 AND CXCR4 MUTATIONS IN CELL-FREE DNA OF PATIENTS WITH IGM MONOCLONAL GAMMOPATHIES
EHA Learning Center, Tina Bagratuni, 215911
NEXT-GENERATION SEQUENCING ALTERNATIVES FOR THE DETECTION AND QUANTIFICATION OF MINIMAL RESIDUAL DISEASE IN MULTIPLE MYELOMA PATIENTS
EHA Learning Center, Alejandro Medina, 215912
CYCLIN D1-MEDIATED GENE EXPRESSION DYSREGULATION IMPACTS MANTLE CELL LYMPHOMA PATHOGENESIS
EHA Learning Center, Silvia Beà Bobet, 215913
TPL2 KINASE HAS A TUMOR SUPPRESSIVE ROLE IN MYC-INDUCED LYMPHOMAGENESIS
EHA Learning Center, ELIAS STAGAKIS, 215914
INSUFFICIENT RECEPTOR EDITING LEADS TO DEFECTIVE B CELL CENTRAL TOLERANCE IN PRIMARY IMMUNE THROMBOCYTOPENIA (ITP)
EHA Learning Center, Zi Sheng, 215915
LABORATORY CHARACTERIZATION OF PATIENTS WITH (SUSPECTED) INHERITED PLATELET DISORDERS: RESULTS FROM THE ‘THROMBOCYTOPATHY IN THE NETHERLANDS’ STUDY
EHA Learning Center, Maaike Blaauwgeers, 215916
A DECREASED PLATELET-TO-LYMPHOCYTE RATIO IS ASSOCIATED WITH A LOW PLATELETCRIT IN PRE-DIABETES
EHA Learning Center, Bongani Nkambule, 215917
THE OXYGENSCAN: CONTINUOUS MEASUREMENT AND QUANTIFICATION OF SICKLING DURING DE- AND REOXYGENATION TO MONITOR DISEASE SEVERITY AND TREATMENT EFFECT IN SICKLE CELL DISEASE.
EHA Learning Center, Minke Rab, 215918
ALLOGENEIC STEM CELL TRANSPLANTATION OVERCOMES THE NEGATIVE PROGNOSTIC IMPACT OF ASXL1 MUTATIONS IN TRANSPLANT ELIGIBLE PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA.
EHA Learning Center, Abhishek Mangaonkar, 215919
HEMATOLOGICAL PHENOTYPES OF DIFFERENT ALPHA-THALASSAEMIA GENOTYPES CAUSING HYPOCHROMIC MICROCYTIC ANEMIA AT NEONATAL PERIOD
EHA Learning Center, thidarat suksangpleng, 215920
INVOLVEMENT OF LEUCOCYTE DERIVED EXTRACELLULAR VESICLES IN THE PROCOAGULANT STATE FOUND IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA-RELATED CONDITION
EHA Learning Center, Adeline Wannez, 215921
INCREASED PLATELET RESPONSE TO ENDOGENOUS AGONISTS, IN PRE-DIABETIC C57BL/6 MICE
EHA Learning Center, Zibusiso Mkandla, 215922
MOXETUMOMAB PASUDOTOX IN HEAVILY PRETREATED PATIENTS WITH RELAPSED/REFRACTORY HAIRY CELL LEUKEMIA: RESULTS OF A PIVOTAL INTERNATIONAL STUDY
EHA Learning Center, Francis Giles, 214465
ALLOGENEIC STEM CELL TRANSPLANTATION FOR PERIPHERAL T-CELL LYMPHOMAS: A STUDY OF 284 PATIENTS FROM THE SOCIÉTÉ FRANCOPHONE DE GREFFE DE MOELLE ET DE THÉRAPIE CELLULAIRE.
EHA Learning Center, Stéphanie Nguyen Quoc, 214471
RAS PATHWAY HYPERACTIVATION IS ASSOCIATED WITH INFERIOR SURVIVAL IN PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA
EHA Learning Center, Klaus Geissler, 214472
A PROSPECTIVE PHASE II STUDY OF DARATUMUMAB IN PREVIOUSLY-TREATED SYSTEMIC LIGHT- CHAIN (AL) AMYLOIDOSIS
EHA Learning Center, arnaud jaccard, 214545
RANDOMIZED COMPARISON OF 90 MG VERSUS 60 MG DAUNORUBICIN IN 7+3 STANDARD INDUCTION FOR NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: RESULTS FROM THE SAL-DAUNODOUBLE TRIAL
EHA Learning Center, Christoph Röllig, 214551
RITUXIMAB INDUCES A PRO-INFLAMMATORY MICROENVIRONMENT THAT INCREASES NOTCH1 SIGNALLING IN CHRONIC LYMPHOCYTIC LEUKAEMIA CELLS.
EHA Learning Center, Jennifer Edelmann, 214555
ANALYSIS OF ANTI-THROMBOPOIETIN RECEPTOR ANTIBODYIES IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA
EHA Learning Center, Takashi Satoh, 214562
HEPCIDIN MIMETIC PTG-300 INDUCES DOSE-RELATED AND SUSTAINED REDUCTIONS IN SERUM IRON AND TRANSFERRIN SATURATION IN HEALTHY SUBJECTS
EHA Learning Center, Richard Shames, 214566
MESENCHYMAL STROMAL CELLS PROTECT ACUTE LYMPHOBLASTIC LEUKAEMIA CELLS FROM CYTARABINE INDUCED APOPTOSIS BY TRANSFER OF MITOCHONDRIA VIA TUNNELLING NANOTUBES IN A TREATMENT RESISTANT NICHE MODEL
EHA Learning Center, Richard Burt, 214611
UNEXPECTED PREVALENCES OF THE JAK2V617F AND CALR MUTATIONS IN THE GENERAL POPULATION
EHA Learning Center, Sabrina Cordua, 214616
VERY LOW DOSE PROPHYLAXIS IN CHILDREN WITH HAEMOPHILIA A: A RURAL INDIAN EXPERIENCE
EHA Learning Center, DIBYENDU DE, 215843
FINAL RESULTS OF A PHASE IB STUDY OF ISATUXIMAB PLUS POMALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA.
EHA Learning Center, Joseph Mikhael, 214463
DECREASED INCIDENCE OF INFECTION, USE OF ANTIBACTERIALS AND DAYS IN HOSPITAL AFTER ADMINISTRATION OF CLT-008 MYELOID PROGENITOR CELLS TO SUBJECTS RECEIVING AML INDUCTION THERAPY: PHASE 2 STUDY RESULTS
EHA Learning Center, Pinkal Desai, 214467
ATRA COULD CORRECT THE IMPAIRED PROPLATELET FORMATION CAUSED BY THE TUBULIN Β1 SINGLE NUCLEOTIDE POLYMORPHISM R307H IN CORTICOSTEROID-RESISTANT ITP PATIENTS
EHA Learning Center, Chen-cong Wang, 214474
A PHASE 1, OPEN-LABEL STUDY TO DETERMINE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF ESCALATING DOSES OF LJPC-401 (SYNTHETIC HUMAN HEPCIDIN) IN PATIENTS WITH IRON OVERLOAD
EHA Learning Center, Vip Viprakasit, 214475
EFFICACY OF VENETOCLAX MONOTHERAPY IN PATIENTS WITH RELAPSED, REFRACTORY MANTLE CELL LYMPHOMA POST BTK INHIBITION THERAPY.
EHA Learning Center, Toby Eyre, 214548

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings